Cervical Cancer APK

Version 4.0 - com.newandromo.dev338923.app609995
newandromo,dev338923,app609995,medical,cervical,cancer

APP Information

Download Version	4.0 (1078)
Apk Size	3.54 MB
App Developer	Fumo
Malware Check	TRUSTED
Install on Android	4.1.x and up
App Package	com.newandromo.dev338923.app609995.apk
MD5	a4d92ae3c7540e0b29a2f09f2c2723fc
Rate	5

Table of Contents

Description
Download
Reviews
ChangeLog
Older Versions
Screens
File Information

Download Cervical Cancer 4.0 APK

Download APK File (3.54 MB) Get from Google Play

App Description

Cervical Cancer is newandromo,dev338923,app609995,medical,cervical,cancer, content rating is Everyone (PEGI-3). This app is rated 5 by 1 users who are using this app. To know more about the company/developer, visit Fumo website who developed it. com.newandromo.dev338923.app609995.apk apps can be downloaded and installed on Android 4.1.x and higher Android devices. The Latest Version of 4.0 Available for download. Download the app using your favorite browser and click Install to install the application. Please note that we provide both basic and pure APK files and faster download speeds than APK Mirror. This app APK has been downloaded 7+ times on store. You can also download com.newandromo.dev338923.app609995 APK and run it with the popular Android Emulators.

Cervical cancer is the third most common malignancy in women worldwide, and it remains a leading cause of cancer-related death for women in developing countries. In the United States, cervical cancer is relatively uncommon.
The incidence of invasive cervical cancer has declined steadily in the United States over the past few decades; however, it remains at high levels in many developing countries. The change in the epidemiologic trend in the United States has been attributed to mass screening with Papanicolaou (Pap) tests, which permits detection and treatment of preinvasive disease.
Recognition of the etiologic role of human papillomavirus (HPV) infection in cervical cancer has led to the recommendation of adding HPV testing to the screening regimen in women 30-65 years of age. However, women who have symptoms, abnormal screening test results, or a gross lesion of the cervix are best evaluated with colposcopy and biopsy.